Incyte's ruxolitinib cream gets positive EU review for eczema
Incyte (Nasdaq: INCY) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
